-
Next Year Will Be Weak For Kimberly Clark; Analyst Says Buy The Stock Anyway
Tuesday, October 24, 2017 - 10:28am | 414Renaissance Macro Research said in a note Tuesday Kimberly Clark Corp (NYSE: KMB) could have another weak year in fiscal 2018. However, the firm said the weakness is already priced into the stock. As such, the firm upgraded shares of Kimberly Clark from Neutral to Overweight, while it...
-
Sterne Agee: Pepsi Should Break Up, Coke Should Accelerate Acquisitions
Friday, February 26, 2016 - 10:44am | 431According to Sterne Agee CRT, PepsiCo, Inc. (NYSE: PEP) needs to break up in order to add more value to shareholders, while The Coca-Cola Co (NYSE: KO) should continue with an acquisition-led diversification strategy. Sterne Agee CRT downgraded both stocks to Neutral from Buy. Pepsi's "Better...
-
Beverage Giants Are Snatching Up Drink Brands, But The Bottom Of The Barrel Isn't In Sight
Tuesday, September 22, 2015 - 3:16pm | 478Recent M&A trends in the alcoholic beverage space highlight the popularity of craft beer. Sterne Agee CRT believes that larger beer names will continue to look for craft buyout targets. The Coca-Cola Co (NYSE: KO)’s investment in Suja is an indication of its continued focus on exposure...
-
Wall Street: Herbalife Not A Pyramid Scheme, Trends Turning Around
Tuesday, August 4, 2015 - 1:46pm | 810Herbalife Ltd. (NYSE: HLF) is scheduled to report its second quarter results after market close on Wednesday. The Estimize community (based on 11 estimates) is expecting the company to earn $1.21 per share on revenue of $1.156 billion, while the Wall Street consensus is looking for the company to...
-
BTIG Reiterates On Herbalife, Says It's Confident Company 'Is Not A Pyramid Scheme'
Monday, January 19, 2015 - 7:39pm | 263BTIG reiterated its Buy rating on Herbalife Ltd. (NYSE: HLF) Friday ahead of its earnings release. The firm maintained a $55 price target. Analyst April Scee noted that consensus “hasn’t yet adjusted for the increase in Fx pressure since HLF guided on 11/03, but market is braced for...
-
How Has Wall Street Behaved Amid The Ackman-Herbalife Drama?
Thursday, January 8, 2015 - 12:56pm | 314Herbalife Ltd. (NYSE: HLF) is down nearly 50 percent over the past six months, but is up more than 3 percent on Thursday. The company is also involved in quite the debate with hedge fund manager Bill Ackman. But what has the rest of Wall Street said about Herbalife in the past few months?...
-
Why BTIG Downgraded Procter & Gamble
Tuesday, December 30, 2014 - 9:11am | 137April Scee of BTIG downgraded Procter & Gamble Co (NYSE: PG) to Neutral on Tuesday after shares traded above the firm's $92 price target. According to Scee, shares of Procter & Gamble have outperformed some of its peers throughout 2014. The analyst notes that the company's "Hundred Brand...
-
BTIG: Nu Skin's China Issues 'Are In The Past, But Will The Difference Be Demonstrated?'
Thursday, December 18, 2014 - 9:07am | 152Following Nu Skin Enterprises, Inc. (NYSE: NUS) Investor Day, April Scee of BTIG Research commented in a note on Wednesday that the company's China issues are in the past. “At its Investor Day last week, management stressed China should begin to inflect and unveiled its innovation agenda and fiscal...
-
UPDATE: BTIG Research Initiates Coverage On Coty Nearing Inflection Point
Wednesday, November 19, 2014 - 10:11am | 107In a report published Wednesday, BTIG Research analyst April Scee initiated coverage on Coty (NYSE: COTY) with a Buy rating and $23.00 price target. In the report, BTIG Research noted, “Nail inflecting & Fragrance should inflect next 12-18mo, aided by launches and Avon relationship. We assume...
-
UPDATE: BTIG Research Initiates Coverage On Jarden On Positive Outlook
Wednesday, November 19, 2014 - 10:02am | 123In a report published Wednesday, BTIG Research analyst April Scee initiated coverage on Jarden Corp. (NYSE: JAH) with a Buy rating and $78.00 price target. In the report, BTIG Research noted, “Jarden brings big company marketing, distribution, & innovation to niche categories, outmatching...
-
UPDATE: BTIG Research Initiates Coverage On Nu Skin Enterprises On Multiple Challenges Ahead
Wednesday, November 19, 2014 - 9:53am | 100In a report published Wednesday, BTIG Research analyst April Scee initiated coverage on Nu Skin Enterprises (NYSE: NUS) with a Neutral rating. In the report, BTIG Research noted, “China must regain momentum to support growth and sentiment likely to remain negative until distributor levels rise,...
-
UPDATE: BTIG Research Initiates Coverage On Church & Dwight Co. On Solid Strategic Potential
Wednesday, November 19, 2014 - 9:50am | 107In a report published Wednesday, BTIG Research analyst April Scee initiated coverage on Church & Dwight Co. (NYSE: CHD) with a Buy rating and $84.00 price target. In the report, BTIG Research noted, “We like Church's Mega Brand Strategy, we believe organic will accelerate in F15, that margins...
-
UPDATE: BTIG Research Initiates Coverage On Energizer Holdings As Positive Factors Are Already Reflected In Valuation
Wednesday, November 19, 2014 - 9:33am | 110In a report published Wednesday, BTIG Research analyst April Scee initiated coverage on Energizer Holdings (NYSE: ENR) with a Neutral rating. In the report, BTIG Research noted, “We believe in the value of the Split & potential for organic growth to accelerate, but margin potential limited post...
-
UPDATE: BTIG Research Initiates Coverage On Herbalife On Significant Upside Potential
Wednesday, November 19, 2014 - 9:28am | 90In a report published Wednesday, BTIG Research analyst April Scee initiated coverage on Herbalife Ltd. NYSE: HLF) with a Buy rating and $55.00 price target. In the report, BTIG Research noted, “Great industry dynamics & strong business model, but this is not the current focus as stock continues...
-
BTIG Issues 'Anti-Preview' On Consumer Staples With Short-Term Convictions
Wednesday, October 8, 2014 - 3:15pm | 390BTIG issued a September-Q "Anti-Preview" on Wednesday. The report expected a weak quarter with a short-term risk/reward for some stocks. Analyst April Scee noted she believed September-Q estimates "are at risk...on (1) slower Asia & Latin America, (2) weak US mass market, (3...